ArticleJournal for immunotherapy of cancer2024

Engineered oncolytic virus expressing B7H3-targeting BiTE enhances antitumor T-cell immune response.

Haoran Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.